The clinical impact of metabolic bone disease in coeliac disease
W E Ficklinga, X A McFarlanea, A K Bhallab, D A F Robertsona
a Department
of Gastroenterology, Royal United Hospital, Bath, Avon BA1 3NG,
UK, b Royal National
Hospital for Rheumatic Diseases, Bath
Correspondence to: Dr Robertson duncan.robertson{at}ruh-bath.swest.nhs.uk
Submitted 28 January 2000;
Accepted 11 July 2000
Bone mineral density was measured by dual energy
x ray absorptiometry (DEXA) at the lumbar
spine and femoral neck in 15 adults who had metabolic bone disease in
association with coeliac disease (mean age at diagnosis 53.5 years,
range 37 to 66). Results were expressed as a T score (the number of
standard deviations by which patient's bone density differed from the
sex matched young adult mean). Three patients had no skeletal symptoms
and normal routine calcium biochemistry but severely reduced axial bone
mineral density on DEXA. Eleven patients had symptomatic skeletal
fractures, including fractures of proximal femur (3), vertebrae (4),
and radius (6). Three patients had osteomalacia confirmed on bone
biopsy, two of whom had characteristic biochemistry. Secondary and
tertiary hyperparathyroidism were seen. Seventy five further
patients (60 female) with coeliac disease (mean age 52.0 years, median
duration of gluten-free diet 3.4 years) and 75 paired healthy age and
sex matched controls were questioned on past fracture history. Patients with coeliac disease underwent detailed studies of calcium
biochemistry, dietary intake, and bone mineral density. Sixteen had a
past history of fractures (
2 = 10.7, p = 0.0004,
v controls), which were of typical
osteoporotic type. Ten patients had fracture before diagnosis of
coeliac disease and six after diagnosis. Patients who had a fracture
were older (56.3 v 50.3 years, p < 0.02,
Wilcoxon rank sum test) than those with no fracture. There was no
significant difference in bone mineral density (z score
0.31
v
0.77), serum calcium (2.30 v 2.26 mmol/l), 25-hydroxyvitamin D (19.7 v 23.7 nmol/l), parathyroid hormone (2.6 v 3.1 pmol/l), or dietary calcium intake
(1021.0 v 1033.0 mg/day) in patients with
fracture compared with those without fracture. Metabolic bone disease
is common in coeliac disease and is associated with premature
osteoporotic fractures.
Keywords: osteoporosis; coeliac disease; dual energy x ray absorptiometry
© 2001 by The Fellowship of Postgraduate Medicine
This article has been cited by other articles:
-
MacLaughlin, E. J., Raehl, C. L., Reilly, C.
(2008). Celiac disease and osteoporosis. Am J Health Syst Pharm
65: 1601-1602
[Full Text] -
Goddard, C J R, Gillett, H R
(2006). Complications of coeliac disease: are all patients at risk?. Postgrad. Med. J.
82: 705-712
[Abstract] [Full Text] -
van Heel, D A, West, J
(2006). Recent advances in coeliac disease. Gut
55: 1037-1046
[Full Text] -
Fisher, A A, Davis, M W, Budge, M M
(2004). Should we screen adults with osteoporotic fractures for coeliac disease?. Gut
53: 154-155
[Full Text] -
Compston, J
(2003). Is fracture risk increased in patients with coeliac disease?. Gut
52: 459-460
[Full Text] -
Thomason, K, West, J, Logan, R F A, Coupland, C, Holmes, G K T
(2003). Fracture experience of patients with coeliac disease: a population based survey. Gut
52: 518-522
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
